[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"ultrasound-assessment\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:ultrasound-assessment":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,46],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":21,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":29,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":45},"100639257","3d-us-construct-on-volumetric-assessment-of-lung-disease--clinical-application-100639257",false,"NCT07574255","3D-US Construct on Volumetric Assessment of Lung Disease & Clinical Application","Three-dimensional Ultrasonic Construct on Volumetric Assessment of Lung Disease and Its Clinical Application","Inclusion Criteria:\n\n* Participants suspect with lung lesions referred for ultrasound workup\n\nExclusion Criteria:\n\n* Participants aged \\\u003C 18 years\n* Participants refusal\n* Participants with implanted metal in scanning area interfering data collection\n* Participants who cannot perform breath holding for at least 1 second","ALL","18 Years",{"count":19,"type":20},300,"ESTIMATED","6 Months","OBSERVATIONAL","The goal of this observational study is to establish the three-dimensional construct of lung lesion via ultrasound in patients with peripheral lung lesions or any superficial lesion in thoracic fields. The primary question our study aims to answer is:\n\nWhether the 3D ultrasound morphology can reflect lung disease entities? Whether the 3D volumetric follow-up protocol can be standardised to reflect lung disease status?",[25,26,27,28],"Lung Ultrasound","Lung Cancer (Diagnosis)","Peripheral Lung Lesions","Ultrasound Assessment",[30,31,32],"lung ultrasound","three-dimensional ultrasound","peripheral lung lesions","NOT_YET_RECRUITING","2026-05-03",{"date":36,"type":37},"2026-05-07","ACTUAL",{"date":39,"type":20},"2026-05-30",{"date":41,"type":20},"2031-02-28",{"name":43,"class":44},"National Taiwan University Hospital","OTHER",1,{"id":47,"slug":48,"hasResults":11,"nctId":49,"briefTitle":50,"officialTitle":51,"acronym":4,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":53,"enrollmentInfo":54,"targetDuration":4,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":63,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":70,"completionDateStruct":72,"leadSponsor":73,"locationsCount":45},"100623593","apremilast-and-adalimumab-in-psoriatic-arthritis-patients-100623593","NCT07398651","Apremilast and Adalimumab in Psoriatic Arthritis Patients","Comparative Study Between Apremilast and Adalimumab in Psoriatic Arthritis Patients","Inclusion Criteria:\n\n* This study will include 60 adult Psoriatic arthritis patients \\>18 years old, fulfilling the (CASPAR) classification criteria of Psoriatic arthritis and have an inadequate response to methotrexate therapy for at least 3 months.\n\n  * Psoriatic arthritis patients with peripheral musculoskeletal domains (peripheral arthritis, dactylitis and enthesitis) as well as skin and nail domains\n\nExclusion Criteria:\n\n* Patients who received previous biologic agents or Janus kinase inhibitors.\n* Patients with axial and ocular involvement.\n* Current or recent serious infection including tuberculosis or hepatitis B\u002FC .\n* Current or past history of malignancy (within five year).\n* Pregnant or breastfeeding women or women planning pregnancy during the study period .\n* Severe uncontrolled comorbidities such as heart failure, severe liver disease, or chronic kidney disease (eGFR \\\u003C30 mL\u002Fmin\u002F1.73m²) .","70 Years",{"count":55,"type":20},60,"INTERVENTIONAL",[58],"NA","The aim of this work is to compare the efficacy of Apremilast combined with Methotrexate versus Adalimumab combined with Methotrexate",[61,28,62],"Psoriatic Arthritis","TNF",[64,65,66],"Psoriatic Arthritis Patients:","Apremilast","Adalimumab","2026-02-09",{"date":69,"type":37},"2026-02-10",{"date":71,"type":20},"2026-12-30",{"date":71,"type":20},{"name":74,"class":44},"Tanta University"]